Theratechnologies Inc T.TH

New Press Release - Theratechnologies Announces Update on its Preclinical Oncology Research Program

Company continues to shift to commercial focus as it seeks partners to advance R&D MONTREAL, March 22, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization...read article.

[Trogarzon]

More cost cutting... good

[palinc2000]

Finally facing reality

[palinc2000]

Bye bye Paul!!! Hope you do the honorable thing and leave silently without breaking the Bank ....Maybe your Montreal Club other directors could help you 

[Trogarzon]

So 50M to contribute to the scientific discourse and understandings... 1.5M charges and Well positioned to leverage..... not even funny... thsi ddiot wasted my whole retirement on understandings... FU. “I am very proud of our exceptional research team, whose work has contributed greatly to the scientific discourse and understanding of advanced cancers,” said Paul Lvesque, President and CEO at

[palinc2000]

Costs would appear to be related to work done at U of M Probably part of the 5 million projected to complete part 3 of Phase 1 .... which will be carried on unless they also decide that it is not seeing any efficacy 

[Trogarzon]

I think their part of the work is done and the 600k non cash writhoff has something to do with it....

[Trogarzon]

It's a better week for Thera...